This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Thursday, March 21, 2013
Entering the new era of hepatitis C
IDCareLive
The Infectious Disease Virtual Congress is an online event that includes all of the features of a live medical conference, including live streaming video lectures, panel discussions and case presentations as well as interactive activities such as real-time question and answer sessions with top faculty and other participants.
Watch renowned national experts present LIVE via streaming video in wide range of infectious disease topics.
No comments:
Post a Comment